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ANNEX 
ABBREVIATIONS AND SYMBOLS 
Ac acetyl 
Ar aryl 
Boc iert-butyloxycarbonyl 
tBu tert- butyl 
DMSO-d6 deuterated dimethylsulfoxide 
Et ethyl 
IR infrared 
Me methyl 
NMR nuclear magnetic resonance 
Ph phenyl 
iPr isopropyl 
nPr «-propyl 
Z benzyloxycarbonyl 
Ch heteroatom effect parameter 
cs substitution effect parameter 
8 chemical shift 
AG Gibbs free energy difference 
AH enthalpy difference 
K [ring]/[chain] 
r correlation coefficient 
p reaction constant 
R universal gas constant 
AS entropy difference 
a+ Hammett-Brown parameter 
T temperature 
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1. INTRODUCTION 
1.1. What is ring-chain tautomerism? 
That type of isomerism in which the isomers differ only in the position of a proton and 
the corresponding location of a double bond is commonly referred to as tautomerism. This 
phenomenon is mainly characteristic of compounds containing polarized double bonds. Enol-
oxo, lactam-lactim, imine-enamine and nitroso-oxime compounds are the most frequently 
encountered tautomeric systems. 
In ring-chain tautomerism, the position of a proton changes via ring opening and ring 
closure. This process occur in two ways: the ring closure can be exo or endo: 
H 
- X : — \ 
dcO — C ^ ™ 
H 
o . X—Y=C 
endo \ v/ ( C. 
C X — 
c 
H ^ 
A well-known example of the exo type of ring-chain tautomerism is to be found in the 
monosaccharides. The mutarotation of monosaccharides can be explained by the interconversion 
of the C-l epimeric ring-closed forms 1A and 1C via the open hydroxy aldehyde (or hydroxy 
ketone) form IB: 
CH2OH CH2OH CH2OH 
— O x O H 
OH > ' > ' H ¿ x . - < b < 
1A IB 1C 
The structures and reactivities of numerous five- and six-membered, saturated, N-
unsubstituted 1,3-X,N heterocycles can be characterized by the endo type ring-chain tautomeric 
equilibrium of the l,3-X,N heterocycles 2B and the corresponding Schiff bases 2A:1"3 
,N=CH 
R ( j f „ X ^ Y ^ R(jT„ 
XH 
2A 2B 
X = O, S, NR' 
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In consequence of their ring-chain tautomeric character, oxazolidines and tetrahydro-1,3-
oxazines can be used as aldehyde sources in carbon-transfer reactions (e.g. the Pictet-Spengler or 
the Hantzsch reaction).4"11 
In the case of biologically active compounds containing a primary amino group and a 
hydroxy, mercapto or amino group (e.g. norephedrine or cysteine), the aldehyde or ketone 
condensational products may be used as prodrugs on the basis of their tautomeric character. 
Continuous drug release can be achieved by the gradual hydrolysis of the open-chain form.12'24 
1.2. Aims 
Oxazolidines and tetrahydro-l,3-oxazines are the groups of saturated 1,3-X,N 
heterocycles whose ring-chain tautomerism has been studied most thoroughly (see section 
2.1.1). For 2-aryl-substituted derivatives of these types of compounds, a clear-cut correlation was 
found between the log Kx values of the equilibria (Kx = [ring]/[chain]) and the Hammett-Brown 
constants CT+ of the substituents X on the 2-aryl group. In both the liquid and gas phases, the 
ring-chain tautomerism of these compounds could be described by Equation l:1 
log K X = p a + + log KX=H (Eq. 1) 
However, the ring-chain tautomerism of the corresponding 1 ,3 -Nf l heterocycles is less well 
known. Ring-chain tautomeric processes in imidazolidines or hexahydropyrimidines have been 
observed in only a few cases, and the effects of the substituents on the tautomeric ratios have not 
yet been studied systematically (see section 2.1.3). For many l,3-N,N heterocycles a complete 
shift of the tautomeric equilibrium towards either the ring form or the open-chain form is 
frequently observed. The aim of my PhD work was to investigate whether certain 2-aryl-l,3 -N,N 
heterocycles exhibit ring-chain tautomerism in solution. We set out to find model compounds 
among the 2-ary l -1 ,3heterocycles that undergo ring-chain tautomerism in solution, and 
which are suitable for studies on the scope and limitations of Equation 1. We planned to 
investigate the electronic and/or steric effects of 1- and 2-substituents, carbocycles fused with 
1,3 -Nfl heterocycles and the relative configuration of the ring anellation on the ring-chain 
tautomerism of these kinds of compounds. 
2. LITERATURE 
2.1. Ring-chain tautomerism of 1,3-X,N heterocycles 
2.1.1. Ring-chain tautomerism of 1,3-0,1$ heterocycles 
The great interest in this topic is demonstrated by the fact that a large number of papers 
and excellent reviews have recently been published on the ring-chain tautomerism of \,3-XJJ 
heterocycles.1"3 
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The ring-chain tautomerism of 1,3-0,A heterocycles was first recognized in the middle 
of the 20th century. COPE and HANCOCK observed that the molar refraction of the product 
obtained by reacting ethanolamine with methyl propyl ketone was changed following distillation. 
They proposed that this phenomenon could be explained by the ring-chain tautomerism of the 
product.23 
MCDONAGH and SMITH obtained the first quantitative data on the ring-chain tautomerism 
of 1,3-0,N heterocycles by means of NMR spectroscopy. 26 In the 'H NMR spectra of 2-aryl-
substituted 3,4-dihydro-2//-l,3-benzoxazines 3 in CDCf, the signal of O-C/ZAr-N (ring form: 
B) appeared at 5.8-5.9 ppm, while that of the corresponding N=CZ/Ar (open form: A) was at 8.2-
8.5 ppm. On integration of these peaks, they found that the electronic character of substituent X 
on the aromatic ring exerts a well-defined influence on the ring-chain ratios. Electron-
withdrawing substituents increased, while electron-donating substituents decreased the 
proportion of the ring form. They suggested a linear correlation between log K (K = 
[ring]/[chain]) and the Elammett constant a of the substituent X.27 
- O H ^ 
X 
i>J 
3A 3B 
X = N 0 2 ( p ) , N 0 2 ( M ) , Br(p), H, CHMe2(p), NMe2(p) 
By investigation of the tautomeric ratios of 2-aryl-substituted oxazolidines 4 , PAUKSTELIS 
and LAMBING found a clear correlation between log [A]/[B] and the Hammett-Brown parameters 
o+ of the substituents X. The correlation coefficient of the regression lines for 2-aryl-l,3-
benzoxazines 3 improved significantly (from -0.993 to -0.999) following this a —» change.28 
,OH 
-O 
IMe-
N' NX-Nq ^ Me \( -Vfx Me H 
4 A 4 B 
X = N0 2 (OT) , C I ( M ) , C I O ) , OMe(M), Me(/?), OMe(p), NMe2(>) 
ALVA ASTUDILLO et al. set up Equation 1 for 2-aryl-substituted oxazolidines. They found 
9Q 
that p is a value characteristic of the compound in question. The equilibrium ratio was 
measured in a large number of solvents and in each case the data gave good linear plots that 
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obeyed Equation 1. This equation was found to be true not only in solution, but also in the gas 
phase.30 
The improved possibilities due to the increase of the power of the magnetic field of NMR 
spectroscopic instruments provided higher accuracy in the determination of the tautomeric ratios. 
FÜLÖP et al. studied the ring-chain tautomeric equilibria of alicycle-fused 2-aryl-substituted 
tetrahydro-l,3-oxazines by means of 400 MHz 'H NMR spectroscopy.31'32 Their results indicated 
that in CDCI3 compounds 5-9 exist as two- (an open and a ring form) or three-component (an 
open and two C-2 epimeric ring fonns) tautomeric mixtures. All series gave a good linear 
correlation in accordance with Equation 1, i.e. Equation 1 also holds when several types of ring 
form are present. The slopes of the regression lines were very similar; the p value of 0.76±0.04 
seems to be characteristic of this ring system. 
- OÇ NH "N "OH 
Q = CH2: 5Aa,b 5Ba,b 
Q = CH2CH2: 6Aa,b 6Ba,b 
y C ^ O H 
N 
Y = CH2: 7Aa,b 7Ba,b 
Y = CH2CH2: 8Aa,b 8Ba,b 
Y = CH=CH: 9Aa,b 9Ba,b 
cis: a, trans: b, Y = N02(p), N02(m), Cl(p), H, CH3(p), OCH3(p), N(CH3)2(p) 
When 3-amino-l,2-propanediol (10) was reacted with aromatic aldehydes, five-
component ring-chain tautomeric mixtures were formed that could be described by Equation 1. 
Thus, the scope of Equation 1 was extended to tautomeric mixtures containing different ring 
forms. Study of such multicomponent tautomeric mixtures has been the topic of a number of 
publications.33"35 
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OH 
X /O. VJ 
OH CHO 
H H 
NH 
l lCa- i 
,OH 
"NH2 
10 
O 
l lEa-i 
X 
OH OH 
V-/ \AN 
H 
-NH 
H 
HO i 
H 
R ° T X 
l lBa-i l lAa-i l lDa-i 
X = N02(7«): a, CN(p): b, Br(«j): c, Br(p):d, Cl(p): e, H: f, Me(p): g, OMe(p): h, NMe2(p): i 
The determination of o+ is possible by means of Equation 1. p values have been 
accurately determined for numerous 1,3-0,N heterocycles, and the electronic character of a 
substituent at position 2 can therefore be calculated according to Equation 1 by measuring the 
ring-chain ratios.36"38 
Through multiple ring-closure reactions of (2i?*,3i?*)-l,4-diamino-2,3-butanediol (12) 
and «ieso-2,3-diamino-l,4-butanediol (14) with j^-substituted benzaldehydes, cz's-l,5-dioxa-3,7-
diazadecalin 13C and tra«s-l,5-diaza-3,7-diaoxadecalin 15C were prepared and their ring-chain 
tautomerism was investigated by STAR et al. These were the first examples of a two-step ring-
chain tautomeric equilibria, which could be characterized by Equation l.39"41 
CH2NH2 
HO-
H-
-H 
-OH 
CH2NH2 
12 
2 ArCHO 
ArHC=N 
OH 
HO 
N=CHAr 
13A 
OH 
N=CHAr 
13B 
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CH2OH 
H NH2 
H NH2 
CH2OH 
14 
I 2 ArCHO 
ArHC= 
HO 
^Ar 
15 A 15B 15C 
Ar = C6H4N02(p), C6H4Br(p), Ph, C6H4Me(p), C6H4OMe(p), C6H4NMe2(p) 
2.1.2. Ring—chain tautomerism of 7,3-S,N heterocycles 
The results of BERGMAN and KALUSZYNER indicated that the condensation products of 
aminothiols with carbonyl compounds possess exclusively cyclic structures.42 By using 400 
MHz NMR spectroscopy, FÜLÖP et al. found no detectable amounts of the open-chain forms A 
in the thiazolidines 16 prepared from 2-aminoethanethiol, or L-cysteine and its ethyl ester with 
aromatic aldehydes:43 
The predominance of the ring-closed tautomer of 1,3-5,TV heterocycles can be explained 
by the enhanced nucleophilicity of the sulfur atom. However, certain indirect evidence points to 
the ring-chain tautomerism of this type of compound. For example, the formation of metal 
chelates, hydrolysis and C-2 epimerization has been used to prove the presence of the open-chain 
form indirectly.44'45 
The first direct NMR spectroscopic evidence of tautomerism in the thiazolidine system 
was found in the case of 17 obtained from 2-aminothiophenol with 5-bromosalicylaldehyde. 
Strong hydrogen-bonds stabilize the open tautomer A, which is present in detectable amounts 
(ca. 4%) both in CDC13 and in DMSO-d6 solution:43,46 
SH 
16A 16B 
R = H, COOH, COOEt; X = H, NMe2(p), OH(o) 2-OH-5-Br 
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SH 
^ ^ ^Br 
N 
HO 
1 7 A 1 7 B 
2.1.3. Ring—chain tautomerism of 7,3-N,N heterocycles 
There are some similarities in the investigations of the ring-chain tautomerism of 1,3-
N,N and 1,3-0,A heterocycles. The first evidence that condensation products of diamine 
derivatives and oxo compounds could be ring-chain tautomeric mixtures was obtained from 
changes in the molar refraction of the products.47 Later, IR and NMR spectroscopy revealed 
more details of this phenomenon.1"3 
The condensation of propylenediamine with formaldehyde was carried out at the 
beginning of the 20th century; the product was thought to be an equilibrium mixture of 
hexahydropyrimidine and its open-chain tautomer. On account of its polymerization properties, 
hexahydropyrimidine base is believed to exhibit ring-chain tautomerism. EVANS observed that 
2,2-dimethylhexahydropyrimidines which were tautomeric mixtures could be reduced to the 
corresponding 3-alkylaminopropylamines (which suggested that it was the double bond of the 
open-chain tautomer which was being reduced), while those possessing cyclic stmctures were 
inert.48'49 
The first quantitative data on 2-aryl-substituted 1,3-N,N heterocycles, including the 
effects of the substituents on the 2-phenyl ring, were published by HARMON et al. The reactions 
of 4-amino-5-aminomethyl-2-methylpyrimidine (18) with substituted benzaldehydes yield cyclic 
products 20 or open products 19 or their mixtures. The ring-chain tautomeric ratios were 
determined by means of 60 MHz 'H NMR spectra, by integrating the characteristic peaks of the 
N-CZ7Ar-N and N=C//Ar protons. No correlation was found between the electronic character of 
the substituent Xand the isomer preferentially formed.50 
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CHO 
ME N NH2 
NH2 + è X 
18 
Me X 
X = F(p), Cl(p), Br(p): 19 X = N02(p), OMe(p), F (p) , 
2,3-diCl, 3,4-diCl: 20 
By means of 60 MHz ]H NMR spectroscopy, C H A P U I S et al. concluded that, in the 
reactions of ethylenediamines with aldehydes or ketones, 1,3 -N,N heterocycles or the 
corresponding Schiff bases were formed. In some cases, the product contained exclusively one of 
these two tautomeric forms; in others, their mixtures were formed. For the products 22-25 
obtained from V-phenylethylenediamine (21) with aliphatic aldehydes, the amount of the cyclic 
tautomer B decreased with increasing steric demand of the alkyl substituent:51 
Through the use of NMR spectroscopy, PARRINELLO and MULHAUPT found that 1-
methyl-2-substituted hexahydropyrimidines 27 and 28, prepared from 1,3-diamines with 
isobutyraldehyde, benzaldehyde or /»-nitrobenzaldehyde, exist exclusively as ring forms in 
CDCI3.52 However, the analogous 1-methylimidazolidine derivatives 30 bearing a branching 
alkyl substituent at position 2 proved to be ring-chain tautomeric mixtures. The ratio found by 
100 MHz 'H NMR spectroscopy for compound 30 in CDCI3 (30A: 22%, 30B: 78%) is consistent 
with the values reported51 by CHAPUIS et al: 
•N 
H 
21 R = Me: 22A (100%) 22B (0%) 
R = Et: 23A (100%) 23B (0%) 
R = z'Pr: 24A (62%) 24B (38%) 
R = tBu: 25A (0%) 25B (100%) 
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CHO 
NHMe 
NH2 
29 
CHO 
Me—|—Me 
Me 
NHMe 
NH2 
26 
c NHMe IT N ^ y Me 
Me Me' 
30A 
X = H, N02 
CHO 
Me^Me 
Me 
Cn > 
XT 
Me 
N Me 
N 
H 
-Me 
Me 
30B 
Polish authors established that the condensation products of V-methyl ethyl enedi amine 
(29) and aromatic aldehydes exist as ring-chain tautomeric mixtures. By using 80 MHz 'H NMR 
spectroscopy, they determined the ring-chain ratios at ambient temperature in different solvents 
(CC14, CDCI3 and DMSO-d6), but did not find any marked solvent dependence.53,54 
CHO 
c NH2 NHMe 
29 
c N NHMe 
31A 
X 
NO2 
H 
NHCOOCHMe2 
NHCOMe 
NMe2 
j55 
31A 
0 
20 
35 
38 
50 
c 
ZELENIN et al. studied the ring-chain tautomerism of some 1-alkylidene or arylidene 
ethylenediamines to imidazolidines 32. It was found that the products obtained with «-aliphatic 
aldehydes do not contain detectable amounts of the open form A, but branching of the alkyl 
substituent R2 increased the proportion of the open form up to 5%. However, the introduction of 
a phenyl group increased the amount of the open-chain tautomer to such an extent that the cyclic 
form B was undetectable. 55 
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32A 32B 
R1 = H, R2 = Me: a; R1 = H, R2 = Et: b; R1 = H, R2 = «Pr: c; R1 = H, R2 = zPr: d; 
R1 = H, R2 = Ph: e; R1 = R2 = Me: f; R1 = Me, R2 = Et: g; R ! = Me, R2 = Pr: h 
By condensations of a number of aromatic aldehydes with propylenediamine, 2-aryl-
substituted hexahydropyrimidines were prepared. For derivatives 33a-g, a good correlation was 
found between log Kx and the Hammett-Brown parameter a+ of para substituents (X): 
log K x = 0.84CT+ + 0.93 (r = 0.99) 
Electron-withdrawing substituents stabilize the cyclic hexahydropyrimidine form 33B. This was 
the first example among l,3-N,N heterocycles of a ring-chain tautomeric process that could be 
described by a Hammett-type equation.56 
X = H: a; X = F: b; X = CI: c; X = Br: d; X = OMe: e; X = NMe2: f; X = NEt2: g 
M O O D I E et al. investigated the reaction between deuterated isobutyraldehyde and 
ethylenediamine by means of ]H NMR spectroscopy and determined the equilibrium constant for 
the formation of 34.57 As a continuation of this work, M O O D I E et al. examined the rates of ring-
chain tautomeric processes in solution ( D M S 0 - d 6 - D 2 0 = 4 : 1 , using excess isobutyraldehyde 
under acid-catalysed conditions) for the deuterated five- 34, six- 35 and seven-membered 36 1,3-
N,N heterocycles. For the imidazolidine and hexahydropyrimidine systems, the equilibrium is 
shifted towards the ring tautomer; for the hexahydropyrimidine, the open tautomer is the 
predominant form.58 
33Aa-g 33Ba-g 
D 
D 
A B 
n = 1: 34; n = 2: 35; n = 3: 36 
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The ring-chain tautomerism of 1,2-diaminoethyl and 1,3-diaminopropyl derivatives of 
various aldoses (rhamnose, glucose (37), mannose, arabinose and galactose) has also been 
1 O 
studied. By means of C NMR, the linear tautomer form A was not found in either case; the 
hexahydropyrimidine form C usually predominates.59 A noteworthy characteristic of this ring-
chain tautomeric equilibrium is that ring-closure of open-chain forms can occur in exo (A —» B) 
or endo (A —» C) ways: 
CH2OH 
HO 
NH(CH2)3NH2 
OH 
37Bp (45%) 
HO | NH(CH2)3NH2 
OH 
n 
N. NH2 
37Bcc (5%) 
n 
HN\ -NH 
H-
HO-
H-
HO-
-OH 
-H 
-OH 
-H 
H-
HO-
H-
HO-
CH2OH 
37A (0%) 
-OH 
-H 
-OH 
-H 
CH2OH 
37C (50%) 
KORBONITS et al. described a rare type of ring-chain tautomerism of 2-aryl-substituted 
1,3 -N,N heterocycles, in which both ring and open forms could be isolated pure and 
interconverted in solution. In the reaction of 3-aminopropionamide oxime (38) with one 
equivalent of benzaldehyde or its derivatives containing electron-withdrawing substituents, 
imines 39A were formed, which equilibrate in solution with the cyclic forms 39B. However, in 
the case of cinnamaldehyde and benzaldehydes containing electron-donating substituents, only 
the open-chain imine tautomers could be detected, either in solution or in the solid state.60,61 
NOH 
| ^ N H 2 
CHO 
NHOH 6 i NHOH 
NH2 
38 
N 
39A 
X = N 0 2 ( « í ) , Cl(p), CL(O), H 
39B 
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PIHLAJA et al. found that the ring-chain tautomeric character of the condensation 
products of anthranilic acid A-methylhydrazide (40) and oxo compounds depends on the type of 
oxo compound used. Carbohydrazides 40 were observed to react with acetaldehyde, acetone and 
cyclohexanone to yield cyclic products 41a-c, whereas open-chain hydrazones 42 were fonned 
with benzaldehyde. The reaction of 40 with acetophenone yielded a ring-chain tautomeric 
mixture of hydrazone 43A and benzotriazepinone 43B in an equilibrium ration of 1 : l.62 
CHO 
41a-c 
43A 43B 
R1 = H, R2 = Me: a; R1 = Me, R2 = Me: b; R1, R2 = -(CH2)5-: c; 
In the reactions of polyamine compounds with aldehydes, multiple ring-closures are 
possible. FUCHS et al. recently prepared stereoisomeric 1,4,5,8-tetraazadecalines (46a,b) from 
meso- (44) and (2i?*,3R*)-l,2,3,4-tetraaminobutane (45) by using a nearly stoichiometric 
amount of formaldehyde. However, the NMR spectra of the products 46 revealed no evidence of 
ring-chain tautomerism.63 
H-
H-
f—NH2 H r—NH2 
NH2 CH2O^ H N ^ N ^ S ^ CH2Q H2N H 
-NH2 trans * J^^NH "" cis H NH2 
NH2 H NH2 
44 cis: 46 a, trans: 46b 45 
2.1.4. Applications of ring-chain tautomerism 
Carbon-transfer reactions, the development of prodrugs, pseudo-proline formation during 
peptide synthesis and selective functionalization of A-monosubstituted ethylene- or 
propylenediamines are detailed here as examples of the practical importance of ring-chain 
tautomerism. 
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In consequence of their ring-chain tautomeric character, oxazolidines and tetrahydro-1,3-
oxazines can be used as aldehyde sources under acidic conditions in different reactions. As 
examples oxazolidines or oxazines 47 transfer their C-2 unit in the Hantzsch or the Pictet-
Spengler reaction to give nifedipine analogues 48, tetrahyro-P-carbolines 49, 
bis(indolyl)methanes 50 or 1-substituted tetrahydroisoquinolines 51 4-11 This approach is 
preferred in those cases where the aldehydes required for the reaction are unstable or difficult to 
access as the 1,3-0,N heterocycles can be readily functionalized at C-2.64 
-fx 
,COOR 
H3C NHR 
COOR 
n = 1, 2; R1 = H, Me, CH2OH, Ph, CH2Ph; R2 = H, Me; R3 = H, Ph; R4 = Me, Et; 
R5 - H, COOMe, COOPr; R6 = CH2Ph, CH2PhOMe(p); R7 = H, Me; R8 = H, OH, OMe 
Many unfavourable pharmacological and physicochemical properties of drugs can be 
improved by the application of prodrugs. Ring-chain tautomeric prodrugs include \,2>-X,N 
heterocycles prepared from difunctional compounds with aldehydes or ketones. From the ring-
chain equilibria of these derivatives, the open form undergoes continuous hydrolysis to give the 
bioactive molecule, which can be either the original difunctional compound or an oxo 
compound. This concept was applied in cases of oxazolidine and thiazolidine prodrugs derived 
from (-)-ephedrine, L-cysteine and hydrocortisone. Studies on 2-aryl-l,3-Y,/V heterocycles 
demonstrate that the transformation of a drug candidate to a ring-chain tautomeric prodrug is 
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always worthy of consideration when the pharmacologically active compound contains a 1,2- or 
1,3-amino alcohol, a diamine or an amino thiol moiety or an oxo group.12 
Among 1 ,3-0,N heterocycles, BUNDGAARD and JOHANSEN described the first ring-chain 
tautomeric prodrugs. The physical-chemical and chemical properties of oxazolidine derivatives 
53 obtained by condensations of (-)-ephedrine (52) with oxo compounds are different from those 
of ephedrine.13'14 Pharmacological investigations of oxazolidine prodrugs have been carried out 
by WALKER et al., who found that oxazolidine prodrugs are less effective than ephedrine. On 
moleculecomplex formation with hydroxypropyl-p-cyclodextrin, the effects on the central 
nervous system of both ephedrine and oxazolidine prodmgs increased.15"20 
X rL tv: x 
Me ; NH M e X N R - H ® M e ^ N = ( 
" M e H Me R2 
52 53A 53 B 
t M I 
R1 = H, Me; R2 = H, Me, Et, «Pr, zPr, tBu, Ph 
Amino acids (L-cysteine and D-penicillamine) bearing mercapto group are liver-
protective agents, but their therapeutic use is limited because of the insufficient absorption and 
bioavailability of these compounds. NAGASAWA et al. prepared 2-substituted thiazolidine-4-
carboxylic acids 55A by ring-closure reactions of L-cysteine (54) with aldehydes. Compounds 
56-58 proved to be liver-protective by preventing the liver damage caused by paracetamol.21"23 
TT J | __ JJ 
HOOCLi.NH2 HOOC I tt HOOC^i .N=CHR X ^ X x — X 
SH s SH 
54 55A 55B 
t H 2 ° I 
R = H, Me, Et, «Pr, w-pentyl, Ph 
It is noteworthy that not only 2-alkyl-thiazolidine-4-carboxylic acids bearing 
hydrophobic substituents, but also 2-alkylthiazolidine-4-carboxylic acids bearing hydrophilic 
substituents at position 2 56-58 proved to be liver-protective. These were prepared by 
condensation of cysteine with polyhydroxy aldehydes.23 
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H 
H 
r X 
S NH 
—OH 
—OH 
—OH 
CH2OH 
5 6 
COOH 
r - r 
S NH 
—OH 
HO—I 
COOH H 
HO— 
—OH 
CH2OH 
5 7 
r K 
S ^ N H 
—OH 
HO— 
—OH 
—OH 
CH2OH 
5 8 
COOH 
Drugs containing a keto group can also be transformed into ring-chain tautomeric 1,3-
heterocyclic derivatives. BODOR et al. prepared spirothiazolidines 6 0 A by condensation of 
hydrocortisone and its 17- and 21-ester derivatives 59 with cysteine esters. The effective steroid 
was liberated by the hydrolysis of the open-chain form. As local anti-inflammatory agents, these 
thiazolidine derivatives have lower systemic toxicity. 24 
OR 
OR 
5 9 
OH 
R 2 O O C / H 
H 
OH 
6 0 A 
H , 0 
OR 
6 0 B 
R1 = H, Ac; R2 = Me, Et 
Pseudo-prolines are versatile tools for overcoming various problems in peptide synthesis. 
They consist of serine (Ser)- or threonine (Thr)-derived oxazolidines 61, 62, and cysteine (Cys)-
derived thiazolidines 63. Pseudo-prolines offer a convenient, temporary protection technique for 
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Ser, Thr or Cys; they can be incorporated into peptides via preformed dipeptides; they interrupt 
the formation of p-sheet structures and prevent peptide aggregation by induction of a kink 
conformation in the peptide backbone and they exert a strong solubilizing effect.65"67 
o 
R'^R2 
Ser, Thr, Cys 
R^-XH 
H©/H7O HOOC' 
R 
R — 
HOOC tv; 
>° N R 
'N 
H 
X = O, R = H: 61A 
R = Me: 62A 
X = S, R = H: 63A 
61B 
62B 
63B 
Thanks to their ring-chain tautomeric character, 1,2-disubstituted saturated \,2>-N,N 
heterocycles can be exploited as intermediates in the selective functionalization of N-
monosubstituted ethylene- or propylenediamines; the selectivity of the reaction is strongly 
influenced by the nature of the substituent at position 2.52'68,69 
The reactions of hexahydropyrimidine derivatives 64 with a number of electrophiles led 
to products of types 65 and 66 or, after hydrolysis, to 67 and 68. The ratio of the compounds 
65/66 or 67/68 depends mostly on the bulkiness of the substituent at C-2 of the starting 64. The 
chemoselectivity of the reaction is less dependent on the nature or the size of the electrophiles.69 
NH2 ( Jf 
(pn 
NHMe 
n = 1: 29 
n = 2: 26 
RCHO 
-H2O N 
\ 
Me 
64 
/ 
( v-N 
H 
( x-N 
»M 
E+ 
N 
\ 
Me 
65 
+ 
N ^ R 
E 
N I 
Me 
66 
H®/H2O 
H®/H2O 
NHL 
i 
NHMe 
67 
NH2 
, E 
N 
I 
Me 
68 
n = 1, 2; R = Me, Et, z'Pr, Ph; E = Ac, Boc, tBuNHCO, BuNHCO, PhNHCO 
This reaction was utilized in the synthesis of the precursors of backbone-modified 
oligonucleotides. W A N G et al. found that the ring-chain tautomeric product prepared from N-(2-
phosphonoethyl)ethylenediamine with benzaldehyde could be selectively acylated on the 
primary amino group by different acylation agents, which allowed exploitation of the possibility 
of selective substitution of the intermediate ring-chain tautomer.68 
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3. RESULTS AND DISCUSSION 
During my experimental work, 2-aryl-substituted, five- and six-membered-1,3-T7,TV 
heterocycles (imidazolidines, hexahydropyrimidines, tetrahydroquinazolines and 
decahydroquinazolines) were synthetized and their ring-chain tautomeric character was 
investigated. The results on five- and six-membered 1,3-TV,TV heterocycles are discussed 
separately. 
3.1. 2-Aryl-substituted imidazolidines 
2-Aryl-imidazolidines were synthetized by ring-closure reactions of TV-methyl- (29), 
ethyl- (75), propyl- (76), isopropyl- (77) and phenyl- (21) substituted ethylenediamines in order 
to provide large differences in steric properties. Diamines 21, 29 and 75-77 are commercial 
products. 7V-Arylethylenediamines 70-74, the starting materials for the synthesis of 1,2-
diarylimidazolidines, were prepared according to the convenient method of PoiNDEXTER et al. by 
reacting equivalent amounts of 2-oxazolidinone (69) with the appropriate substituted aromatic 
• • 7 0 79 
amine hydrochlorides (Scheme 1). To provide large differences in electronic properties, p-
nitro (70), w-chloro (71), p-methyl (72), /?-methoxy (73) and p-dimethylamino (74) derivatives 
were chosen besides the unsubstituted TV-phenylethylenediamine (21). 
i NH2-HC1 
Model compounds 78-87 were prepared by the reactions of TV-methyl- (29), TV-ethyl- (75), 
7V-(«-propyl)- (76), TV-isopropyl- (77) and TV-phenylethylenediamine (21) and 7V-(substituted 
phenyl)ethylenediamines 21, 70-74 with equivalent amounts of substituted benzaldehydes 
(Schemes 2 and 3). 
69 Y = P N 0 2 : 70 
Y = «îCl: 71 
Y = pMe: 72 
Y =/?OMe: 73 
Y = pNMe2: 74 
Scheme 1 
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CHO 
c NHR NH2 NHR N=CH 
R =Me: 29 78Aa-i 78Ba-i 
R =Et: 75 79Aa-i 79Ba-i 
R =«Pr: 76 80Aa-i 80Ba-i 
R =z'Pr: 77 81Aa-i 81Ba-i 
R =Ph: 21 82Aa-i 82Ba-i 
X = N02(p): a, N02(«z): b, Br(«z): c, Br(p): d, Cl(p): e, H: f, Me(p): g, OMe(p): h, NMe2(p): i 
Scheme 2 
The ]H NMR spectra of compounds 78-87 revealed that all of these compounds (except 
81i, in which no ring form could be detected) participated in a ring-chain equilibrium in CDCI3 
solution at 300 K. 
CHO 
N H -
NH2 
^NH 
N=CH 
Y=pN02: 70 83Aa-i 83Ba-i 
Y = mC\: 71 84Aa-i 84Ba-i 
Y = H: 21 82Aa-i 82Ba-i 
Y = /»Me: 72 85Aa-i 85Ba-i 
Y = jpOMe: 73 86Aa-i 86Ba-i 
Y = /?NMe2: 74 87Aa-i 87Ba-i 
X = N02(p): a; N02(w): b; B r ( m ) : c; Br(p): d; Cl(p): e; H: f; Me(p): g; OMe(p): h; NMe2(p): i 
Scheme 3 
The ratios of the concentrations of the ring and chain forms for the tautomeric equilibria 
were determined in most cases by integration of the well-separated N-C//Ar-N (ring) and 
N=C//Ar (chain) proton singlets. (Tables 1 and 2). Through the use of HMBC and HMQC 
spectroscopy, not only could the characteristic N-C//Ar-N and N=C//Ar singlets be 
distinguished, but also the methylene signals of the ring and open forms. This was especially 
useful in the case of some /z-methoxy- and p-dimethylamino-substituted derivatives, where 
tautomeric ratios could be determined only by integrating the methylene signals, because of the 
overlapping or coalesced lines. 
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Table 1. Ring percentages (B) in tautomeric equilibria for compounds 78-82a at 300 K 
Comp 
-ound X 
+ a 78
a 
R = Me 
78b 
R = Me 
79 
R = Et 
80 
R = «Pr 
81 
R = z'Pr 
82a 
R = Ph 
82b 
R = Ph 
a pN02 0.79 93.4 94.8 84.0 85.4 33.4 68.6 56.0 
b «ÎN02 0.73 94.4 95.3 85.8 85.9 34.8 68.0 55.0 
c mBx 0.405 89.4 93.6 75.2 73.4 17.3 52.6 38.7 
d pBx 0.15 86.8 89.1 69.5 69.0 12.2 46.1 31.3 
e pC\ 0.114 86.6 90.1 68.6 67.8 10.5 42.4 29.6 
f H 0 83.5 85.6 60.3 60.1 8.1 35.7 21.0 
g pMe -0.311 78.9 79.7 48.2 50.3 5.1 27.5 14.7 
h p OMe -0.778 68.2 71.3 37.9 37.0 3.1 15.8 8.3 
i /?NMe2 -1.7 43.6 c 16.7 14.9 ~ 0 4.6 2.2 
aFor the equilibria in CDCI3. bFor the equilibria in DMSO-d6. °Because of overlapping 
coalesced lines, the tautomeric ratio could not be determined at 300 K. 
Table 2. Ring percentages (B) in tautomeric equilibria for compounds 82-87 in CDC13 at 300 K 
Comp. 83 84 82 85 86 87 
Y pN02 mCl H pMe pOMe pNMe2 
X + a 0.79 0.4 0 -0.311 -0.778 -1.7 
a pN02 0.79 57.4 62.2 68.6 71.9 69.4 73.3 
b «ÎN02 0.73 49.9 62.2 68.0 70.5 62.2 66.4 
c mBt 0.405 45.6 49.5 52.6 56.2 63.9 55.8 
d pBr 0.15 39.4 41.6 46.1 48.1 46.0 46.6 
e pC\ 0.114 37.0 39.9 42.4 45.0 42.6 45.4 
f H 0 37.7 35.2 35.7 37.1 33.3 34.5 
g pMe -0.311 30.8 26.9 27.5 28.4 25.6 26.9 
h i?OMe -0.778 18.5 16.5 15.8 18.1 16.7 16.1 
i pNMe2 -1.7 6.2 5.6 4.6 5.2 4.3 2.7 
It is noteworthy that the ratio of the open form of the /7-nitrophenyl-substituted N-
methylimidazolidine (78aA) in CDCI3 was found to be 6.6%, in contrast with the literature52'53 
data (0%). 
The interconversion of ring-chain tautomers, i.e. the mobility of the equilibria, is 
unequivocally proved by the difference in the tautomeric ratios for //-methyl- (78) and //-phenyl-
substituted imidazolidines 82 in CDCI3 and DMSO-dg. For 1-phenyl-imidazolidines 82, similarly 
\ 
to the analogous 1,3-0,// heterocycles,73 the cyclic forms are preferred in CDCI3, while the open 
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forms are rather preferred in DMSO-d6, which is due to the different hydrogen-bonding abilities 
of these solvents. However, for 1 -methylimidazolidines 78, the proportions of the ring forms 
were somewhat higher in DMSO-d6 than in CDCI3. The solvent had only small, but unequivocal 
effects on the slopes of the regression lines in both series of compounds. 
When Equation 1 was applied to the log Kx values, good linear correlations were 
obtained versus the Hammett-Brown parameter aT of the substituent X on the 2-phenyl group 
for all sets of imidazolidines (78-87) (Figures 1 and 2, Table 3). 
To the best of our knowledge, these are the first examples among 2-arylimidazolidines of 
ring-chain tautomeric processes characterized by a Hammett-type correlation. The first 
application of Equation 1 to describe a ring-chain tautomeric process among 2-aryl-l,3-7V,7V 
heterocycles was published for 2-arylhexahydropyrimidines (see section 2.1.3).56 
log K 
2 H 
-2 
-1 
0 
cr 
-2 -1 0 
Figure 1. Plots of log K (in CDCI3) for 78 (•), 79 (o), 80 (•), 
81 (v) and 82 (•) vs Hammett-Brown parameter ct+ 
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log K 
1 -> 
o 
-1 
- 2 
Fig. 2. Plots of log K for (83): (84): o, (82): (85): (86): • 
and (87): • vs Hammett-Brown parameter cr+ 
Table 3. Linear regression analysis data on compounds 78-87 and 
the parent 2-aryloxazolidines (88)74 
Compd. No. of points Slope
3 
(P) 
Intercept3 Correlation coefficient ch
b 
78° 9 0.53(2) 0.75(4) 0.990 1.85 
78d 8 0.61(4) 0.84(6) 0.970 -
79° 9 0.59(3) 0.25(6) 0.984 1.35 
80° 9 0.62(2) 0.25(5) 0.989 1.35 
81c 8 0.82(5) -0.97(7) 0.973 0.13 
82° 9 0.67(1) -0.20(3) 0.997 0.90 
82d 9 0.72(2) -0.48(5) 0.993 -
83° 9 0.49 (3) -0.27 (6) 0.991 0.83 
84e 9 0.58 (0) -0.25 (1) 0.999 0.85 
85e 9 0.67 (2) -0.15 (4) 0.997 0.95 
86e 8 0.68 (4) -0.20 (9) 0.989 0.90 
87e 7 0.77 (3) -0.20 (6) 0.996 0.90 
88e 7 0.60(4) -1.10(2) 0.989 0 
Standard deviations are given in parentheses. bRelative ring stability parameter. 
Tor the equilibria in CDCI3. dFor the equilibria in DMSO-d6. 
The data in Table 2 show that the constants p (in CDCI3) for 1-phenyl- (0.67) and 
especially 1-isopropylimidazolidines (0.82) are greater than the usual p values3 for oxazolidines 
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(0.50-0.60), while those for 1-methyl- (0.53), 1-ethyl- (0.59) and 1 -(w-propyl)imidazolidines 
(0.62) are very similar to the usual values for oxazolidines. The significant differences in p for 
compounds 78-87 suggests that for imidazolidines, in contrast with 1,3-0,TV heterocycles, the 
value of p is not characteristic of the ring system. 
The equilibria of imidazolidines 78-87 in CDCI3 involve a considerable amount of the 
ring form, despite the 5 -endo-trig ring-closure process of the tautomeric forms (A B) 
according to Baldwin's rules.75,76 A comparison of the intercepts (the Ch value is the heteroatom 
effect parameter, which is calculated as the difference in intercept for the given 2-
arylimidazolidine and the parent unsubstituted 2-aryloxazolidine, and expresses the effect of the 
heteroatom on the stability of the ring form) reveals that the ratios of the ring forms in the 
tautomeric equilibria of TV-methyl-, TV-ethyl-, TV-(w-propyl)- and TV-phenylimidazolidines are 
markedly higher than those for oxazolidines. 
The steric effect of the a-carbon of the TV-substituent plays a cmcial role in the addition 
of the NHR group to the C=N bond. An increase in the steric requirement of the TV-substituent, 
i.e. the number of methyl groups on the carbon adjacent to the nitrogen (TV-Me -> TV-Et -»TV-zPr), 
decreased the ratio of the ring forms in the tautomeric equilibria. However, introduction of a 
methyl group onto the (i-carbon of the TV-substituent (TV-Et -» TV-nPr) did not significantly 
influence the intercept values. The proportion of the ring form increases in the following 
sequence of TV-substituents: zPr < Ph < nPr « Et < Me. 
According to the data in Table 3, the value of p in Equation 1 is markedly influenced by 
the electronic character of substituent Y on the 1-phenyl group. A more electron-donating 
substituent Y produces a higher p value. This means that differences in the ring-chain tautomeric 
ratios in a set of 2-aryl-substituted imidazolidines are decreased by introducing an electron-
withdrawing substituent onto the nitrogen. Our efforts to find a mathematical relationship 
between the electronic parameters of substituent Y and the value of p have not resulted in an 
acceptable correlation. The electronic character of Y did not have a significant effect on the log 
KX=H values in Equation 1. 
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3.2. 2-Aryl-substituted hexahydropyrimidines, tetra- and decahydroquinazolines 
The reduction of nitrogen-containing functional groups is the most commonly used 
method for the synthesis of 1,2- and 1,3-diamines. Reductions of aminonitriles, 
aminocarboxamides, diazides and aminoazides are usually carried out by catalytic hydrogénation 
or with metal hydride complexes.77"79 
Of the 1,3-diamines required for the synthesis of hexahydropyrimidines, A-methyl- (26) 
and A-isopropylpropylenediamine (110) were commercial products, while A-
phenylpropylenediamine (91) was prepared by the reduction of p-alanine anilide (90) with 
LiAlH4. The starting materials for the tetrahydroquinazolines, 2-(methyl-, isopropyl- or 
phenylaminomethyl)anilines (96-98), were synthetized by similar reductions of the appropriate 
A-substituted-aminocarboxamides (93-95), obtained by the ring-opening reactions of isatoic 
anhydride (92) with the appropriate amines (Scheme 4);80'82 
o o 
II 1. CICOOEt II 
r OH 2. HiNPh ri^NHPh LiAIH, r A NHPh 
N H Z 3. HBr/CH3COOH NH 2 N H 2 
89 
O 
90 
H 2 N R ^ R Q J A N H R L I A I H ^ R 
N ^ O 
H 
NH 2 
91 
©CNHR 
N H 2 
92 R = Me: 93 
R = zPr: 94 
R = Ph: 95 
Scheme 4 
96 
97 
98 
Starting materials for the synthesis of decahydroquinazoline model compounds were 
prepared from cis- and tra«s-2-aminocyclohexanecarboxylic acid (99a,b) by a combination of 
• RT RFI 
standard chemical procedures (Scheme 5). " cis- and tra«5-2-(Methyl- or isopropyl or 
phenylaminomethyl)cyclohexylamines (107a,b, 108a,b and 109a,b) were synthesized by LiAlHU 
reduction of the corresponding A-substituted-aminocarboxamides (104a,b, 105a,b and 106a,b), 
which were obtained either by the direct amidation of amino esters 100a,b with 
methylamine83'85'86 or via the A-protected amino acids 101 a,b by using the mixed anhydride 
method:84 
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aCOOH 
NHZ 
101a,b 
ZCl a COOH NH2 
99a,b 
1. CICOOEt 2. R-NH2 
R = /Pr, Ph 
EtOH 
SOCU 
MeNH, 
a COOEt NH2 
100a,b 
R = Me 
Of NHR HBr AcOH 
O 
NHR 
NH2 
LiAlH4 
- n r 
NHR 
R = z'Pr: 102a,b 
R = Ph: 103a,b 
R = Me:107a,b 
R = z'Pr: 108a,b 
R = Ph: 109a,b 
R = Me: 104a.b 
R = z'Pr: 105a,b 
R = Ph: 106a,b 
Z = COOCH2C6H5; cis: a, trans: b 
Scheme 5 
Model compounds 111-113, 114-116 and 117-122 were prepared by the condensation of 
propylenediamines (26, 91 and 110), o-aminobenzylamines (96-98) or alicyclic diamines (107-
109a,b) with equivalent amounts of the appropriate substituted benzaldehydes under mild 
conditions (in MeOH, at ambient temperature, 1 h) (Schemes 6 and 7): 
CHO 
NHR 
NH2 
R = Me: 26 
R = z'Pr: 110 
R = Ph: 91 
CNHR 
N 
l l l A a - i 
112Aa-i 
113Aa-i 
l l l B a - i 
112Ba-i 
113Ba-i 
X 
CHO 
o o ™ 
^ ^ NH2 ecNHR NR X 
R = Me: 96 114Aa-i 114Ba-i 
R = z'Pr: 97 115Aa-i 115Ba-i 
R = Ph: 98 116Aa-i 116Ba-i 
X = N02(p): a; N02(m): b; Br(p): c; H: d; Me(p): e; OMe(p): f; NMe2(p): g 
Scheme 6 
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NHR cr 
107-109a,b 
+ 
CHO 
H H 
'NHR 
H 
R = Me, cis: 117B 
R = Me, trans: 118B 
R = z'Pr, cis: 119B 
R = z'Pr, trans: 120B 
R = Ph, cis: 121B 
R = Ph, trans: 122B 
117A 
118A 
119A 
120A 
121A 
122 A 
117C 
118C 
119C 
120C 
121C 
122C 
X = N02(p): a, Br(nz): b, Cl(p): c, H: d, Me(p): e, OMefc): f, NMe2(p): g 
Scheme 7 
The ]H NMR spectra of 112, 113, 115, and 116 in CDC13 solution at 300 K revealed that 
these compounds participate in ring-chain tautomeric equilibria of the 1,3-N,N heterocycles (B) 
and the corresponding Schiff bases (A). In CDCI3 solution at 300 K, cis- and trans-3-isopropyl-
2-aryldecahydroquinazolines (119a-g, 120a-g) and trans-3-phenyl-substituted 2-
aryldecahydroquinazolines (122a-g) participated in three-component (r'-o-r2) ring-chain 
tautomeric equilibria, having both electron-donating and electron-withdrawing substituents on 
the 2-phenyl ring. For cz's-3-phenyl-2-aryldecahydroquinazolines (121), ring-chain tautomeric 
equilibria could be detected only for compounds bearing an electron-withdrawing substituent X 
(121a-c); for the 2-phenyl derivative (121d) and the compounds with an electron-donating 
substituent X on the 2-phenyl ring (121e-g), only the presence of the open-chain tautomer was 
observed. However in the spectra of the A-methyl-substituted-hexahydropyrimidines ( l l la ,g) , 
tetrahydroquinazolines (114a,g) and cis- and trazzs-decahydroquinazolines (117a,g and 118a,g), 
no open-chain tautomeric forms (A) could be detected. Despite the electron-donating p-
dimethylamino substituent on the 2-phenyl ring, which is favourable for the shift of the 
equilibrium towards the open tautomer, l l l g , 114g, 117g and 118g proved to be exclusively 
ring-closed tautomers. The predominance of the ring-closed forms in the case of the A-methyl-
substituted-hexahydropyrimidines ( l l l a ,g ) is in accordance with the literature data on 2-phenyl 
and 2-(p-nitrophenyl) derivatives (Tables 4-6).52'69 
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Table 4. Proportions (%) of ring forms (A) in tautomeric equilibria 
(CDCI3,300 K) for compounds 111-116 
Compd. X + a 111 112 113 114 115 116 
a pN02 0.79 -100 26.2 11.2 -100 99.2 97.5 
b mN02 0.73 - 24.4 9.2 - 99.2 96.4 
c pBr 0.15 - 12.3 5.5 - 97.9 83.1 
d H ~0 - 7.6 5.9 - 95.9 75.2 
e pMe -0.311 - 4.9 3.0 - 92.1 64.1 
f pOMe -0.778 - 2.2 2.3 - 87.3 46.8 
g pNMe2 -1.7 -100 -0 1.1 -100 72.6 16.5 
Table 5. Proportions (%) of ring forms (B and C) in tautomeric equilibria 
for cis compounds 117,119 and 121 (CDCI3,300 K) 
Compd. X + <T 117B 117C 119B 119C 121B 121C 
a pN02 0.79 91.3 8.7 66.6 6.0 11.4 5.3 
b mBr 0.405 - - 57.2 3.0 1.6 -0 
c pCl 0.114 - - 48.3 4.3 1.5 -0 
d H 0 - - 42.8 1.3 -0 -0 
e pMe -0.311 - - 37.5 -0 -0 -0 
f pOMe -0.778 - - 25.7 -0 -0 - 0 
g pNMe2 -1.7 -100 -0 11.1 - 0 - 0 -0 
Table 6. Proportions (%) of ring forms (B and C) in tautomeric equilibria 
for trans compounds 118,120 and 122 (CDCI3, 300 K) 
Compd. X + <T 118B 118C 120B" 120C" 122Bb 122Cb 
a pN02 0.79 -100 -0 89.5 4.6 54.0 14.0 
b mBr 0.405 - - 73.7 10.8 29.3 6.6 
c pCl 0.114 - - 82.4 5.4 24.5 3.6 
d H 0 - - 85.0 4.0 18.2 3.9 
e pMe -0.311 - - 77.7 4.9 10.3 1.3 
f pOMe -0.778 - - 63.8 2.6 5.0 0.5 
g pNMe2 -1.7 -100 -0 32.3 - 0 1.1 -0 
"The proportions of the ring forms were determined by deconvolution because of the 
overlapping lines. bThe proportions of the tautomeric forms of 122a-f measured at 
233 - 273 K were extrapolated to 300 K by using the van't Hoff equation. 
The proportions of the chain (A) and ring forms (B and C) of the tautomeric equilibria 
(Kx) were determined at 300 K by integration of the well-separated N-CHAr-N (ring) and N=CH 
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(chain) proton singlets in the 'H NMR spectra of compounds 111-122. For compounds 120, the 
proportions of the ring-closed tautomers were calculated by deconvolution because of their 
partly overlapping N-CHAr-N singlets (Tables 4-6). 
For compounds 122, tautomeric ratios (Kx) could not be determined at 300 K because of 
the fast interconversion of the tautomeric forms; the signal of the minor ring form therefore 
appeared only at lower temperatures in the [H NMR spectrum. Values of Kx and the proportions 
of the ring forms at 300 K for compounds 122 (Tables 7 and 8) were calculated according to the 
van't Hoff Equation 2 on the basis of the tautomeric ratios determined at lower temperatures:87 
In Kx = -AH/RT + AS/R (Eq. 2) 
Table 7. Proportions (%) of ring forms (B and C) in tautomeric equilibria 
for compounds 122a-f in CDC13 at 233 - 273 K 
Compd. 233 K 237 K 241 K 245 K 249 K 253 K 263 K 273 K 
122 aB 59.3 55.3 55.9 56.0 56.6 57.0 55.6 56.8 
122aC 31.9 29.9 28.8 26.4 25.9 24.1 21.8 19.0 
122bB 51.2 50.5 50.6 50.6 47.9 47.6 47.3 51.2 
122bC 22.0 20.1 18.2 16.7 14.5 12.8 ~0 ~0 
122cB 36.3 36.4 36.6 36.6 35.9 35.4 31.6 30.9 
122cC 20.6 18.9 17.3 15.9 14.5 12.3 8.5 2.1 
122dB 29.1 29.6 29.3 28.9 28.7 28.4 25.7 23.2 
122dC 14.4 13.1 11.8 10.0 8.7 6.0 ~0 - 0 
122eB 19.2 18.6 19.3 17.7 18.7 17.0 14.1 14.6 
122eC 16.4 15.4 13.0 11.6 8.5 7.0 1.4 ~0 
122fB 9.1 9.6 9.4 9.2 8.3 8.3 6.8 6.8 
122fC 4.4 4.3 4.1 3.7 3.1 2.3 1.6 ~0 
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Table 8. Values of -AH/R and -AS/R for compounds 122a-f 
Compound" -AH/Rb -AS/Rb Correlation coefficient K (300 K) 
122aB 906 (81) 2.50 (0.04) 0.961 1.693 
122aC 1797 (129) 6.87 (0.04) 0.980 0.418 
122bB 1525(113) 5.87 (0.05) 0.973 0.457 
122bC 2438 (310) 10.65 (0.07) 0.953 0.081 
122cB 1009 (88) 4.44 (0.05) 0.957 0.342 
122cC 2433 (192) 11.10(0.08) 0.970 0.050 
122dB 902 (91) 4.46 (0.05) 0.942 0.234 
122dC 2855(385) 13.53 (0.11) 0.970 0.050 
122eB 1025 (126) 5.57 (0.07) 0.917 0.117 
122eC 3069 (314) 14.44 (0.09) 0.960 0.015 
1221B 855 (90) 5.79 (0.04) 0.947 0.053 
122fC 2716(271) 14.35 (0.09) 0.961 0.005 
"For compound 122g, the value of K for the equilibrium 
122gB 122gA was determined from the spectrum at 300 K as the 
amount of the minor ring form (122gC) was ~ 0. bStandard deviations 
are given in parentheses. 
The spectra of compounds 111-116 could be interpreted more easily than those for 
compounds 119-122 because the ring-chain tautomeric equilibria of the latter compounds 
contained two diastereomeric ring forms besides the open-chain form. In consequence of the 
very similar NMR spectroscopic characters of these 2-aryldecahydroquinazolines, with the same 
V-substituent and ring anelation, determination of the relative configurations of the major and 
minor ring-closed tautomers and conformational analysis were performed only for the p-
nitrophenyl derivatives 117a-122a (Table 9). 2-Aryl substituents did not change the sequence of 
the chemical shifts of the characteristic N-GfiTAr-N and N=C//Ar protons. 
In the EXSY spectra of 119a and 120a, there is a negative cross-peak between the 
N=Ci/Ar singlet of the open form and both N-C/fAr-N signals of the major and minor ring 
forms, while there is no negative cross-peak between the N-CHAr-N signals of the cyclic 
tautomers. This proves the interconversion of the ring-closed tautomers (B and C) through the 
open-chain form (A). The relative configurations of the major ring-closed tautomers of 119a and 
120a were deduced from the NOESY spectra, in which the cross-peak for the protons at 
positions 2 and 8a proves their cis arrangement (B) (Scheme 7). The same relative configuration 
of H-2 and H-8a for the major ring-closed tautomer was found for all the remaining 2-(p-
nitrophenyl)decahydroquinazolines (117a, 118a, 121a and 122a). In the ring-chain tautomeric 
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equilibria of the corresponding 2-aryldecahydro-3,l-benzoxazines (8a,b), the major ring-closed 
tautomeric form also had cz'r-arranged H-2 and H-8a.31 
Table 9 . Selected characteristic chemical shifts (ppm, 8TMS - 0 ppm) 
and coupling constants (Hz) for compounds 117a-122a 
Compound H-2 H-4e, H-4a* H-4a H-8a V(4e9,4a) V(4flx,4a) 
117aB 3.81 2.87 2.42 1.60 3.05 2.01 3.53 
117aC 4.07 2.70 2.63 1.67 2.80 5.29 <1 
118aB 3.88 2.97 2.02 1.45 2.27 3.53 11.08 
119aAa 8.39 2.46 2.36 1.79 3.61 b b 
119aB 4.39 2.81 2.59 1.67 3.02 2.27 3.27 
119aC 4.58 3.16 2.62 1.66 2.96 b b 
120aAa 8.39 2.40 2.54 1.33 3.10 b b 
120aB 4.44 2.97 2.18 1.39 2.28 3.53 9.06 
120aC 5.04 2.85 2.54 1.32 3.08 3.02 11.58 
121aAa 8.35 3.06 2.92 1.98 3.66 7.55 5.79 
121aB 5.90 3.32 3.20 1.70 3.20 b b 
121aC 5.03 3.67 3.35 2.22 3.72 <1 5.38 
122aAa,c 8.38 2.98 2.87 2.05 3.07 b b 
122aBc 5.94 3.63 2.81 1.45 2.28 3.27 11.58 
122aCc 5.06 3.51 2.75 1.63 2.47 3.02 11.33 
aThe protons of the open form (A) are numbered according to the corresponding protons 
of the quinazoline ring forms (B and C). bCoupling constants were not available 
because of overlapping lines and the low proportion of the tautomeric form at 
equilibrium. °Data from the spectra run at 253 K. 
The configuration of the azomethine double bond was determined by observing the 
intensity of the NOE interaction between H-2 and H-8a in model compounds which contain the 
open tautomeric form in higher proportiona (121a and 122a).A high-intensity NOESY cross-
peak can be detected for both compounds, which suggests the E configuration of the C=N double 
bond and shows that the H(8a)-C(8a)-N(l)-C(2) torsion angle is within the region of ±60°. 
The data in Tables 5 and 6 indicate that the proportions of the diastereomeric ring-closed 
tautomers in the equilibria, which are proportional to the relative stabilities of these ring forms, 
are greatly influenced by the relative configurations of the chiral centres. In an attempt to find a 
relationship between the relative stability and the predominant conformation of the ring epimers, 
a conformational analyis of cis- and irans-3-isopropyl-2-(p-mtrophenyl)decahydroquinazolines 
(119a and 120a) was performed by using NMR and modelling means. An earlier conformational 
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analysis on decahydroquinazoline derivatives led to the conclusion that cri-fused derivatives 
could exist in two interconvertible chair-chair conformations (N-in or N-out), the equilibrium of 
which was strongly dependent on the substitution of the nitrogen at position 1. For 1-
unsubstituted cri-decahydroquinazolines, the conformational equilibrium is shifted dominantly 
towards the N-in conformer, while the 1-methyl cis derivative can be characterized by a 
O/R OO OQ 
dominant N-out conformation. ' ' 
The conformation for 119aB (major ring form) can readily be determined by analysis of 
the crucial NMR spectral parameters. The coupling constants of the signals of the protons at 
positions 4a and 4 are similar, 3J (H-4^, H-4a) = 2.27 Hz and 3J (H-4nx, H-4a) = 3.27 Hz, and 
low, which suggests an equatorial orientation of H-4a relative to the heterocyclic ring. NOE 
interactions can be detected from H-2 to H-4ax and H-8a, which is evidence of a predominantly 
equatorial aryl group, in accordance with its steric demand. On the basis of these results, it can 
be concluded that the major ring-closed tautomer 119aB predominantly occupies an N-in 
conformation (Scheme 8). The low relative concentration of the minor ring-closed tautomer 
119aC did not facilitate the extraction of useful NMR data, and therefore a standard 
conformational search procedure90 was carried out to find the lowest energy conformation. The 
resulting structure (Scheme 8) of 119aC displays an N-out conformation with the sterically 
demanding aryl group in the equatorial position. The energy difference between 119aB and 
119aC, estimated from the average ring-ring tautomeric ratio, is approximately 6.6 kJ/mol. The 
steric repulsion between H-4^ and H-6^ and the repulsion between H-2 and H-8^ in 119C may 
account for the observed stability difference. 
Ar Ar 
119A 119B 
119A 
Ar 
119C 
Scheme 8 
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The major trans ring-anellated diastereomer 120aB exhibits a vicinal coupling constant 
(V(H-4a, H-4e?) - 3.53 Hz and V(H-4a, H-4flX) - 9.06 Hz) and NOE interaction (H-2-H-4«, H-
2-H-8a) pattern which is in accordance with the expected conformation, with the aryl group in 
an equatorial position (Scheme 9). The residual amount of the minor component in the sample 
made molecular modelling necessary. The conformational search for the minor epimer 120aC 
gave a chair-chair conformation in which the aryl group has an axial orientation (Scheme 9). The 
axial position of the 2-aryl group explains the lower stability (AG = 2.9 kJ/mol) of 120aC as 
compared with 120aB. 
When Equation 1 was applied to the log Kx values, good linear correlations were 
obtained vs the Hammett-Brown parameter cri of the substituent X on the 2-phenyl group for 
compounds 112, 113, 115, 116, 119, 120 and 122 (Figure 3 and 4, Table 10). Compounds 119, 
120 and 122 are the first examples among 2-aryl-1,3-N,W heterocycles of three-component ring-
chain tautomeric processes characterized by a Hammett-type correlation. The shift of the 
tautomeric equilibrium towards the open-chain tautomer meant that a linear correlation could not 
be calculated for the few plots for compounds 121. 
120A 120B 
120A 
120C 
Scheme 9 
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Figure 3. Plots of log K (in CDCl3) for 112 (A), 113 (•), 115 (•) and 116 (•) v.v 
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Figure 4. Plots of log K (in CDCl3) for 119B (•), 120B (•), 120C (A), 122B (•) and 122C (>) vs 
Hammett-Brown parameter o 
The linear regression analysis data in Table 10 show that the slope p for 
isopropylhexahydropyrimidines (112: 0.77) has approximately the same value as that for the 
corresponding six-membered 1,3-0,N heterocycle ' (126: 0.74), while p for 1-
phenylhexahydropyrimidines (113: 0.42) is considerably smaller. The 3-phenyl-substituted-
tetrahydroquinazolines (116) have a markedly higher p value (0.93) than those for the 2-
isopropyl-tetrahydroquinazolines (115) and 2-aryl-3,l-benzoxazines (125). The slopes for 3-
substituted-2-aryldecahydroquinazolines (119, 120 and 122) lie within a wider range (0.51-1.21) 
than those for the corresponding 2-aryldecahydro-3,l-benzoxazines (8a,b: 0.55-0.64). 
Furthermore, the significant differences in p for 33, 112 and 113 or for 115 and 116 suggest that 
for the six-membered 1,3-N,N heterocycles, in contrast with the 1,3-0,N heterocycles-' and 
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similarly to the imidazolidines, the value of p is not characteristic of the ring system, and 
depends strongly on the A-substituent. While A-isopropyl-heterocycles 112 and 115 have very 
similar p values, the p values for A-phenyl derivatives 113 and 116 are very different 
Table 10. Linear regression data on compounds 112, 113, 115, 116, 119, 120 and 122. cis- and 
?nms-2-aryldecahydro-3,l-benzoxazines (8a, b),31 2-arylhexahydropyrimidines (33 f". 2-aryl-
3,1-benzoxazines (123)31 and 2-aryltetrahydro-l,3-oxazines (124)1' 
Equilibrium No. of 
points 
Slope3(p) Intercept3 Corr. coeff. 
Substitution 
effect (cs)b 
Heteroatom 
effect (ch)b 
112A — B 6 0.77(3) -1.04(4) 0.997 — -0.89 
113A — B 7 0.42(3) -1.28(6) 0.988 - -1.13 
33A — B 7 0.84(1) 0.93(1) 0.99 — 1.08 
124 A — B 7 0.74(6) -0.15(5) 0.984 — 0 
115A — B 7 0.72(7) 1.49(14) 0.978 2.53 0.38 
116A — B 7 0.93(8) 0.67(16) 0.984 1.95 -0.44 
123 A — B 7 0.78(3) 1.11(2) 0.997 1.26 0 
119A — B 7 0.51(2) -0.06(4) 0.994 0.98 -0.72 
120A — B 7 0.57(8) 0.72(16) 0.957 2.00 -0.40 
120A — C 6 0.71(10) -0.43(12) 0.952 0.85 0.26 
122A — B 7 0.85(5) -0.59(10) 0.985 0.69 -1.71 
122 A — C 6 1.21(9) -1.39(11) 0.988 -0.11 -0.70 
8aA — Bc 7 0.60(2) 0.66(3) 0.998 0.81 0 
8aA — Cc 7 0.60(6) -0.45(12) 0.978 -0.30 0 
8bA — Bc 7 0.55(6) 1.12(12) 0.973 1.27 0 
8bA — Cc 7 0.64(3) -0.69(6) 0.995 -0.54 0 
aStandard deviations are given in parentheses. bRelative ring stability constant, see the 
text. cFor compounds 8a and 8b. j l linear regression analysis of the remeasured tautomeric 
equilibria was performed separately for the equilibria involving C-2 epimeric ring forms. 
H H H 
cis: 8aB 8aA 8aC 
trans: 8bB 8bA 8bC 
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OH 
N ' 
123A 123B 
YH 
X 
Y = O: 124A 124B 
Y = NH: 33A 33B 
Similarly as with the analogous 1,3-0,TV heterocycles,31 a condensed benzene ring 
increases the stability of the ring form (c f . 112 and 115 or 113 and 116). For the 
tetrahydroquinazolines 114-116 and the related 3,1-benzoxazine 123, the TV-phenyl substituent 
causes the strongest destabilizing effect and the stability of the ring-closed form increases in the 
following sequence of Y: NPh < O < Nz'Pr < NMe. 
Ring anellation does not seem to influence the value of p: cis- and tra«s-3-isopropyl-2-
aryldecahydroquinazolines have very similar values of p (0.51 and 0.57). The substituent on the 
nitrogen exerted a similar effect on the value of p to that found for 3-isopropyl and 3-phenyl-
substituted 2-aryl-l,2,3,4-tetrahydroquinazolines: the value of p was somewhat higher for 3-
phenyl derivatives for the equilibria involving either the major (120B-122B) or the minor (120C-
122C) ring forms. 
Both the substituent on the nitrogen and the ring anellation caused marked effects on the 
value of the intercept. To characterize the effects of the anellated ring on the stability of the ring 
form, a substitution effect parameter (cs) was calculated as the difference in intercept for the 
given 2-aryldecahydroquinazolines and the corresponding 2-arylhexahydropyrimidines (112 and 
113) bearing the same substituent on the nitrogen. This kind of relative ring stability constant 
was introduced earlier for the saturated 2-aryl-l,3-0,V heterocycles bearing substituents at 
positions 4-6. ' Positive values of cs mean a more stable ring form relative to the corresponding 
2-arylhexahydropyrimidine. The values of cs for compounds 119B, 120B, 120C, 122B and 122C 
indicate that the anellated ring had a considerable stabilizing effect on the ring form for each 
compound except 122C. This effect was more pronounced for the Y-isopropyl-substituted 
derivatives 119 and 120 than for the TV-phenyl compounds 122. For 3-isopropyl- and 3-
phenyldecahydroquinazolines, the tra/zs-anellated cyclohexane ring (120B: cs = 2.00) had a 
higher stabilizing effect than that of the cis ring anellation (119B: cs = 0.98). The lack of a 
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stabilizing substituent effect in the czs-3-phenyldecahydroquinazolines (121) led to a nearly 
quantitative shift of the equilibria toward the open-chain tautomers (121 A). 
The effect of the substituted nitrogen atom at position 3 on the stability of the ring-closed 
tautomeric form can be expressed by a heteroatom effect parameter (ch). The nitrogen substituent 
causes a marked effect not only on the value of p, but also on the intercept. The value of Ch refers 
to the stability difference between the given 1,3-0,TV and 1,3-AT,TV heterocycles. 
For the six-membered 1,3-7,7V heterocycles 33 and 111-113, the value of ch is minimal 
for the TV-phenyl substituent, and the stability of the ring-closed form increases in the following 
sequence of 7: NPh < NzPr < O < NH < NMe. 
There is no clear connection between the values of Ch and the type of the substituent on 
the nitrogen, but the data in Table 10 demonstrate that the ring form for compounds 119B, 120B, 
122B and 122C is less stable than that for the corresponding decahydrobenzoxazine. Since the 
ring-chain tautomeric equilibria of cis- and ira«j-3-methyl-substituted decahydroquinazolines 
(117 and 118) are appreciably shifted towards the ring-closed tautomer, the stability of the ring-
closed form of cis and irazzs-2-aryldecahydroquinazolines and -3,1-benzoxazines increases in the 
following sequence of the heteroatom at position 3: NPh < NzPr < O < NMe. 
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4. METHODS 
Details of syntheses, physical and analytical data on new compounds described in the 
thesis, and descriptions of NMR spectroscopic analyses of tautomeric equilibria can be found in 
the experimental part of the enclosed publications. 
5. SUMMARY 
During my PhD studies, 1-alkyl- or 1-aryl-substituted 2-arylimidazolidines, 
hexahydropyrimidines, tetrahydroquinazolines and decahydroquinazolines were prepared and 
their ring-chain tautomerism was investigated. The scope and limitations of Equation 1, and 
steric and/or electronic effects of substituents at positions 1 and 2, and of carbocycles condensed 
with 1,3-7V,7V heterocycles on the tautomeric equilibria were studied. 
1. By ring-closure reactions of TV-methyl- (29), ethyl- (75), propyl- (76), isopropyl- (77), 
phenyl- (21), p-nitro- (70), w-chloro- (71), p-methyl- (72), p-methoxy- (73) and p-
dimethylaminophenylethylene diamines (74), TV-methyl- (26), TV-isopropyl- (110) and 7V-
phenylpropylenediamines (91), 2-(methyl-, isopropyl- or phenylaminomethyl)anilines (96-
98) and cis- and inms-2-(methyl-, isopropyl or phenylaminomethyl)cyclohexylamines 
(107a,b, 108a, b and 109a,b) with substituted benzaldehydes, TV-substituted 2-
arylimidazolidines 78-87 2-arylhexahydropyrimidines 111-113, 2-aryltetra- 114-116 and 
decahydroquinazolines 117-122 were prepared and their ring-chain tautomeric character was 
investigated. 
2. The ring-chain tautomeric ratios of the prepared 1,3-TV^ V heterocycles were determined from 
the !H NMR spectra of the tautomeric equilibria by integration of the characteristic N-CTTAr-
N (ring) and N=C77Ar (chain) proton singlets. 
3. Imidazolines 78-87, TV-isopropyl- (112) and TV-phenylhexahydropyrimidines (113) and 
tetrahydroquinazolines (115 and 116) were found (except for 81i and 112g in which no ring 
form could be detected) to participate in a ring-chain equilibrium in CDCI3 solution at 300 
K. cis- and iraws-3-Isopropyl-2-aryldecahydroquinazolines (119a-g, 120a-g) and trans-3-
phenyl-substituted 2-aryldecahydroquinazolines (122a-g) participated in three-component 
(r'-o-r2) ring-chain tautomeric equilibria in CDCI3 solution at 300 K. For cw-3-phenyl-2-
aryldecahydroquinazolines (121), ring-chain tautomeric equilibria could be detected only for 
compounds bearing an electron-withdrawing substituent X (121 a-c). However, in the spectra 
of the TV-methyl-substituted hexahydropyrimidines (llla,g), tetrahydroquinazolines (114a,g) 
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and cis- and /razw-decahydroquinazolines (117a,g and 118a,g), no open-chain tautomeric 
forms (A) could be detected. 
4. For compounds existing as ring-closed and open-chain tautomers, the tautomeric equilibria 
could be described by Equation 1: log Kx = pc+ + log KX=H (1)- To the best of our 
knowledge, among the five-membered l,3-iV,iV heterocycles the 2-arylimidazolidines 
described in the thesis are the first examples of ring-chain tautomeric processes characterized 
by a Hammett-type correlation, cis- and iram-3-Isopropyl-2-aryldecahydroquinazolines 
(119,120) and /ranj-3-phenyl-2-aryldecahydroquinazolines (122) are the first 2-aryl-l,3-JV,iV 
heterocycles with three-component ring-chain tautomeric equilibria characterized by a 
Hammett-type equation. 
5. The wider range of p values for the different 1,3-N,N heterocycles suggests that, for the five-
and six-membered 1,3-N,N heterocycles, in contrast with the 1,3-0,N heterocycles, the value 
of p is not characteristic of the ring system, and depends strongly on the iV-substituent. 
6. Both the substituent on the nitrogen and the presence of an anellated ring were found to 
cause marked effects on the value of the intercept. To characterize the effects of the anellated 
ring on the stability of the ring form (similarly to 2-aryl-1,3-0,N heterocycles), a substitution 
effect parameter (cs) was calculated. A positive value of cs means more stable ring form 
relative to the corresponding 2-arylhexahydropyrimidine. A similar heteroatom effect 
parameter (Ch) was introduced to express the effect of the substituted nitrogen atom at 
position 3 on the stability of the ring-closed tautomeric form; it refers to the stability 
difference between the given 1,3-0,N and 1,3-N,N heterocycles. 
For five-membered 1,3 -Y,N heterocycles, the stability of the ring form increases in the 
following sequence of the hetero atom Y: O < Nz'Pr < NPh < N«Pr ~ NEt < Nme; for six-
membered hexahydropyrimidines the sequence of Y is: NPh < Nz'Pr < O < NH < NMe; for 
the tetrahydroquinazolines 114-116 and the related 3,1-benzoxazine 123, the sequence of 7is 
NPh < O < Nz'Pr < NMe; while for cis and /razw-2-aryldecahydroquinazolines 117-122 and 
-3,1-benzoxazines, the stability of the ring-closed form increases in the following sequence 
of the heteroatom at position 3: NPh < Nz'Pr < O < NMe. An anellated aromatic ring was 
found to cause a higher stabilizing effect than that of the cyclohexane ring anellation. A trans 
anellated cyclohexane ring proved to cause a higher stabilizing effect than that of the cis ring 
anellation. 
7. The protons at positions 2 and 8a in the major ring-closed tautomers of all prepared 
decahydroquinazolines were found to be cw-arranged (B). For cis- and trans-3-
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isopropyldecahydroquinazolines (119a and 120a), conformational analysis was performed. 
The cis major ring-closed tautomer 119aB was found to occupy predominantly an N-in 
conformation. The major trans ring-anellated cyclic diastereomer 120aB had a chair-chair 
conformation, with the aryl group in the equatorial position. Because of the low relative 
concentration of the minor ring-closed tautomer of both 119aC and 120aC, a standard 
conformational search procedure was carried out to find the lowest energy conformation. The 
resulting structure of 119aC indicated an N-out conformation having the sterically 
demanding aryl group in the equatorial position. For 120aC, a chair-chair conformation was 
found, where the aryl group occupies an axial orientation. 
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